The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T-Cell Lymphotropic Virus Type 1

被引:0
|
作者
Giovanna Tosi
Greta Forlani
Vibeke Andresen
Marco Turci
Umberto Bertazzoni
Genoveffa Franchini
Roberto S Accolla
机构
[1] University of Insubria,Department of Experimental Medicine
[2] University of Bergen,Institute of Medicine, Hematology section
[3] University of Verona,Department of Life and Reproduction Sciences, Section of Biology and Genetics
[4] National Cancer Institute,Animal Models and Retroviral Vaccines Section
关键词
Restriction Factor; Viral Transactivator; Pathogen Antigen; Viral Restriction; Endogenous Restriction;
D O I
10.1186/1742-4690-8-S1-A171
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] An interferon signature is associated with disease but not viral containment in chronic infection with the human T-cell lymphotropic virus type 1
    Tattermusch, S.
    Skinner, J.
    Chaussabel, D.
    Banchereau, J.
    Berry, M.
    O'Garra, A.
    Taylor, G.
    Bangham, C.
    IMMUNOLOGY, 2010, 131 : 188 - 188
  • [42] Cell-Free versus Cell-to-Cell Infection by Human Immunodeficiency Virus Type 1 and Human T-Lymphotropic Virus Type 1: Exploring the Link among Viral Source, Viral Trafficking, and Viral Replication
    Dutartre, Helene
    Claviere, Mathieu
    Journo, Chloe
    Mahieux, Renaud
    JOURNAL OF VIROLOGY, 2016, 90 (17) : 7607 - 7617
  • [43] The role of cytotoxic T lymphocytes in human T-cell lymphotropic virus type 1 infection
    Asquith, B
    Bangham, CRM
    JOURNAL OF THEORETICAL BIOLOGY, 2000, 207 (01) : 65 - 79
  • [44] MECHANISMS OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I VIRAL-ASSOCIATED MYELOPATHY
    LIPTON, HL
    BANDYOPADHYAY, P
    ANNALS OF NEUROLOGY, 1994, 36 (02) : 127 - 128
  • [45] Coding potential of the X region of human T-cell leukemia/lymphotropic virus type II
    Ciminale, V
    DAgostino, DM
    Zotti, L
    ChiecoBianchi, L
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 13 : S220 - S227
  • [46] SPASTIC ATAXIA ASSOCIATED WITH HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-II INFECTION
    HARRINGTON, WJ
    SHEREMATA, W
    HJELLE, B
    DUBE, DK
    BRADSHAW, P
    FOUNG, SKH
    SNODGRASS, S
    TOEDTER, G
    CABRAL, L
    POIESZ, B
    ANNALS OF NEUROLOGY, 1993, 33 (04) : 411 - 414
  • [47] THE FIRST AUSTRALIAN CASE OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-II INFECTION
    BOLTON, WV
    BEST, SJ
    DAVIS, AR
    KENRICK, KG
    WYLIE, BR
    MEDICAL JOURNAL OF AUSTRALIA, 1994, 161 (07) : 451 - 451
  • [48] IMMUNOGLOBULIN PROPHYLAXIS AGAINST HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-II IN RABBITS
    MORISHITA, N
    ISHII, K
    TANAKA, Y
    SAWADA, T
    HOSHINO, H
    FOUNG, SKH
    MIYOSHI, I
    JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (03): : 620 - 623
  • [49] Is human T-cell lymphotropic virus type I more clever than human immunodeficiency virus type 1?
    Hrdy, DB
    CLINICAL INFECTIOUS DISEASES, 1999, 29 (05) : 1356 - 1356
  • [50] SEROEPIDEMIOLOGY OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I/II IN NORTHEASTERN BRAZIL
    MOREIRA, ED
    RIBEIRO, TT
    SWANSON, P
    SAMPAIO, C
    MELO, A
    BRITES, C
    BADARO, R
    TOEDTER, G
    LEE, H
    HARRINGTON, W
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1993, 6 (08) : 959 - 963